Last reviewed · How we verify

NCT06228118

Clinical Trail of the Lay User Study and Method Comparison Study of Human Chorionic Gonadotropin (HCG) Test System

Completed Last updated 30 January 2024
What this trial tests

trial in Early Pregnancy in 502 participants. Completed in 2 September 2023.

Timeline
4 August 2023
Primary endpoint
2 September 2023
2 September 2023

Quick facts

Lead sponsorAndon Health Co., Ltd
StatusCompleted
Study typeOBSERVATIONAL
Enrollment502
Start date4 August 2023
Primary completion2 September 2023
Estimated completion2 September 2023
Sites1 location across China

Conditions studied

Sponsor

Andon Health Co., Ltd — full company profile →

Who can join

Adults 18 to 55, female only, with Early Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial consisted of lay user study and method comparison study. Method comparison study: evaluate the clinical performance by comparing the results of new device and FDA cleared device (the comparator) tested on the same sample by professionals. Lay user study: evaluate the usability of by comparing the results of new device on the same sample tested by professionals and lay user, and by lay users complete the questionnaire.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Early Pregnancy

Currently open trials in the same condition.

Other Andon Health Co., Ltd trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06228118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing